LifeEDIT Therapeutics Overview
- Year Founded
-
2017
- Status
-
Acquired/Merged
- Employees
-
88
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
LifeEDIT Therapeutics General Information
Description
Developer of a genome editing platform designed for dna modifications. The company offers rna-guided nucleases, base editors, reverse transcriptase editors, epigenetic editors, delivery systems and manufacturing processes, enabling biopharmaceutical firms to identify therapeutic candidates for genetic disorders.
Contact Information
Website
www.lifeeditinc.comCorporate Office
- 300 Morris Street
- Suite 300
- Durham, NC 27701
- United States
Corporate Office
- 300 Morris Street
- Suite 300
- Durham, NC 27701
- United States
LifeEDIT Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
LifeEDIT Therapeutics Patents
LifeEDIT Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026003754-A1 | Novel reverse transcriptases and uses thereof | Pending | 25-Jun-2024 | ||
| AU-2025222029-A1 | Novel rna-guided nucleases and proteins for polymerase editing | Pending | 12-Feb-2024 | ||
| WO-2025174908-A1 | Novel rna-guided nucleases and proteins for polymerase editing | Pending | 12-Feb-2024 | ||
| WO-2025083619-A1 | Rna-guided nucleases and acive fragments and variants thereof and methods of use | Inactive | 18-Oct-2023 | ||
| AU-2024361267-A1 | Rna-guided nucleases and active fragments and variants thereof and methods of use | Pending | 18-Oct-2023 | C12N9/22 |
LifeEDIT Therapeutics Signals
LifeEDIT Therapeutics Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
LifeEDIT Therapeutics FAQs
-
When was LifeEDIT Therapeutics founded?
LifeEDIT Therapeutics was founded in 2017.
-
Where is LifeEDIT Therapeutics headquartered?
LifeEDIT Therapeutics is headquartered in Durham, NC.
-
What is the size of LifeEDIT Therapeutics?
LifeEDIT Therapeutics has 88 total employees.
-
What industry is LifeEDIT Therapeutics in?
LifeEDIT Therapeutics’s primary industry is Drug Discovery.
-
Is LifeEDIT Therapeutics a private or public company?
LifeEDIT Therapeutics is a Private company.
-
What is LifeEDIT Therapeutics’s current revenue?
The current revenue for LifeEDIT Therapeutics is .
-
Who are LifeEDIT Therapeutics’s investors?
AgBiome has invested in LifeEDIT Therapeutics.
-
When was LifeEDIT Therapeutics acquired?
LifeEDIT Therapeutics was acquired on 16-Nov-2020.
-
Who acquired LifeEDIT Therapeutics?
LifeEDIT Therapeutics was acquired by ElevateBio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process